(Taken from abstract) Recent advances in molecular biology have made possible the use of genes as therapeutic agents for a variety of congenital and acquired diseases including AIDS. Stem cell gene therapy for AIDS offer several potential advantages including protection of the multiple lineage of the hematopoietic cells susceptible to HIV infection as well as long-lived reconstitution. There are considerable barriers to the stable integration and expression of foreign genes in hematopoietic cells in vivo and experiments in non-human primates offer the opportunity to address these issues in an in vivo experimental model. Recent studies from this laboratory have demonstrated that the introduction of either an RNA decoy or SIV specific ribozyme into primitive CD34+ hematopoietic cells can induce a relatively high level of resistance to SIV infection in both T-cells and macrophages derived from these cells. The objective of this proposal then is to examine the ability of hematopoietic stem and progenitor cells transduced with these genes to engraft in normal and SIV infected macaques and to give rise to the hematopoietic cells resistant to SIV infections.
Three specific aims are proposed.
Specific Aim 1 : To optimize engraftment of hematopoietic stem cells transduced with candidate therapeutic genes in normal macaques.
Specific Aim 2 : To examine the ability of RNA decoy and SIV specific ribozyme to protect hematopoietic cells from SIV infection in vivo.
Specific Aim 3 : To examine the ability of genetically-modified hematopoietic stem cells to engraft and differentiate SIV-infected macaques.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA073473-04
Application #
6150055
Study Section
AIDS and Related Research Study Section 1 (ARRA)
Program Officer
Yovandich, Jason L
Project Start
1997-02-10
Project End
2002-01-31
Budget Start
2000-02-01
Budget End
2002-01-31
Support Year
4
Fiscal Year
2000
Total Cost
$327,621
Indirect Cost
Name
Harvard University
Department
Type
Schools of Medicine
DUNS #
082359691
City
Boston
State
MA
Country
United States
Zip Code
02115
Braun, Stephen E; Taube, Ran; Zhu, Quan et al. (2012) In vivo selection of CD4(+) T cells transduced with a gamma-retroviral vector expressing a single-chain intrabody targeting HIV-1 tat. Hum Gene Ther 23:917-31
Kimpel, Janine; Braun, Stephen E; Qiu, Gang et al. (2010) Survival of the fittest: positive selection of CD4+ T cells expressing a membrane-bound fusion inhibitor following HIV-1 infection. PLoS One 5:e12357
Zahn, R C; Hermann, F G; Kim, E-Y et al. (2008) Efficient entry inhibition of human and nonhuman primate immunodeficiency virus by cell surface-expressed gp41-derived peptides. Gene Ther 15:1210-22
Braun, Stephen E; Lu, Xiaobin V; Wong, Fay Eng et al. (2007) Potent inhibition of simian immunodeficiency virus (SIV) replication by an SIV-based lentiviral vector expressing antisense Env. Hum Gene Ther 18:653-64
Braun, Stephen E; Johnson, R Paul (2006) Setting the stage for bench-to-bedside movement of anti-HIV RNA inhibitors-gene therapy for AIDS in macaques. Front Biosci 11:838-51
Braun, Stephen E; Wong, Fay Eng; Connole, Michelle et al. (2005) Inhibition of simian/human immunodeficiency virus replication in CD4+ T cells derived from lentiviral-transduced CD34+ hematopoietic cells. Mol Ther 12:1157-67
Rosenzweig, M; Connole, M; Glickman, R et al. (2001) Induction of cytotoxic T lymphocyte and antibody responses to enhanced green fluorescent protein following transplantation of transduced CD34(+) hematopoietic cells. Blood 97:1951-9
Rosenzweig, M; MacVittie, T J; Harper, D et al. (1999) Efficient and durable gene marking of hematopoietic progenitor cells in nonhuman primates after nonablative conditioning. Blood 94:2271-86